Core Insights - Windtree Therapeutics has significantly reduced its outstanding shares of Series C and Series D Preferred Stock, with a 99.3% reduction in Series C and a 68.5% reduction in Series D as of July 25, 2025 [2][4] - The company has launched a BNB crypto treasury strategy, with an initial investment of $60 million led by Build and Build Corp, and plans for up to $700 million in BNB acquisitions [3][4] - The price of BNB coin has increased by over 17% since the announcement of the crypto treasury agreement, indicating strong global demand for the coin [3] Company Developments - As of July 25, 2025, only 19 shares of Series C Preferred Stock and 1,161 shares of Series D Preferred Stock remain outstanding, reflecting a substantial reduction in potential dilution from preferred conversions [2][4] - Investors redeemed approximately $2.3 million worth of preferred shares, which could have been converted into around 7.7 million common shares [4] - Windtree is actively seeking long-term development partners for its therapeutic pipelines alongside its cryptocurrency initiatives [5] Strategic Partnerships - Build and Build Corp, which is leading the investment in Windtree's crypto treasury strategy, is backed by notable investors and has a strong background in hedge funds and digital asset management [6]